Filter
1719
Filtered Results: 1719
Text search:
drug
formulations
Featured
Recommendations
189
New Publications
554
Language
Document type
No document type
1060
Guidelines
294
Studies & Reports
197
Manuals
67
Strategic & Response Plan
44
Training Material
21
Fact sheets
21
Situation Updates
5
Infographics
4
Brochures
2
Resource Platforms
2
App
1
Online Courses
1
Countries / Regions
India
103
Kenya
71
Uganda
53
Tanzania
43
Global
41
Malawi
37
Nepal
36
South Africa
35
Ethiopia
34
Liberia
32
Sierra Leone
29
Ghana
28
Nigeria
28
Zambia
27
Rwanda
26
Bangladesh
24
Philippines
22
Namibia
22
Zimbabwe
21
Myanmar / Burma
21
Latin America and the Carribbean
20
Western and Central Europe
19
Cambodia
17
Africa
16
Botswana
12
Lesotho
11
Senegal
11
Indonesia
10
Eswatini/ Swaziland
10
South–East Asia Region
9
Cameroon
8
Haiti
7
Congo, Democratic Republic of
7
Burkina Faso
6
Eastern Europe
6
Ukraine
5
Syria
5
Russia
5
Benin
4
Albania
4
Asia
4
Pakistan
4
Tajikistan
3
Thailand
3
Mozambique
3
Eastern Europe and Central Asia
3
Georgia
3
South Sudan
3
Madagascar
3
North Macedonia
2
Iran
2
Afghanistan
2
Guinea
2
USA
2
Middle East and North Africa
2
Western Pacific Region
2
North America
2
Gabon
2
United Kingdom
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Lebanon
2
Vietnam
2
Sri Lanka
2
Sudan
2
Libya
2
Colombia
1
Timor Leste/ East Timor
1
Australia
1
Gambia
1
Kazakhstan
1
Chile
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Peru
1
Malaysia
1
Morocco
1
Venezuela
1
Jordan
1
Ireland
1
Saudi Arabia
1
Paraguay
1
Turkmenistan
1
Denmark
1
France
1
Tunisia
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Moldova
1
Yemen
1
Greece
1
Mali
1
Bhutan
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
748
Clinical Guidelines
249
Public Health
79
Women & Child Health
78
Key Resources
41
Capacity Building
24
Pharmacy & Technologies
24
Toolboxes
HIV
178
TB
168
Pharmacy
111
AMR
104
Mental Health
90
NTDs
64
COVID-19
49
NCDs
28
Caregiver
27
Rapid Response
26
Ebola & Marburg
21
Refugee
16
Planetary Health
12
Disability
11
Health Financing Toolbox
8
Global Health Education
8
Specific Hazards
6
Cholera
6
Conflict
6
Natural Hazards
5
Polio
5
Malaria
4
Social Ethics
3
Zika
3
The 2011-2012 National Annual Report on HIV program presents the progress in implementing the strategies and activities articulated in the National Strategic Plan on HIV and AIDS 2009-2012, commonly referred to as the HIV NSP.
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an ...
French version of "Developing Pharmacy Practice" - WHO/FIP Joint handbook - Ce manuel expose un nouveau paradigme de pratique pharmaceutique. Il a pour but de guider les enseignants en pharmacie pour qu’ils intègrent cette nouvelle pratique pharmaceutique, de former les étudiants ...
The Bolivarian Republic of Venezuela has been facing a sociopolitical and economic situation that has negatively impacted social and health indicators. There have been intensified population movements both within the country and to other countries, particularly to Argentina, Brazil, Chile, Colombia,...
The checklist and reference list has two parts: high-level cross-cutting content (Part A) and specific programme content (Part B). Part A applies to all countries and contains situation and response analysis, the NSP development process, the goal, targets and priority-setting of the NSP and the prin...
Published: February 23, 2010
https://doi.org/10.1371/journal.pmed.1000235
Volume 7 | Issue 2 | e1000235
BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421
Antibiotic resistance is no longer a concern for the distant future but is a pressing issue, both globally and in Nepal. As part of global effort to preserve the effectiveness of antibiotics, the Global Antibiotic Resistance Partnership (GARP)-Nepal was established to doc...
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med...
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally....
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
October 2009 | Volume 6 | Issue 10 | e1000162
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
